You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《盈警響號》普華和順(01358.HK)料上半年輸液器業務收入按年下跌35%至45%
阿思達克 07-06 17:56
普華和順(01358.HK)公布,預期集團於今年上半年將錄得來自集團輸液器業務之收入較去年同期的1.72億元人民幣大幅下降35%至45%之間。集團指,輸液器業務之收入預期下降主要由於今年初開始爆發新型冠狀病毒疫情,中國若干地區的醫院人流量大幅減少以及中國實施旅行限制。集團已密切關注市場狀況,調整其業務策略及運營,以便降低負面影響。

集團又指,財務狀況及現金流量保持穩健。除不明朗的情況及面臨包括疫情在中國的發展情況及市場狀況在內的因素影響以外,目前預計集團今年下半年的收入與上半年相比將有所提高。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account